News

CBO finds health agency cuts would result in fewer new drugs
The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...
KFF Health News5d
NIH, FDA Cuts Would Lead To Fewer New Meds, CBO Analysis Indicates
An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
STAT20d
How an erosion of staff expertise threatens Marty Makary’s FDA | STAT
FDA employees are spooked by increasing political involvement in regulatory decisions, frustrated by the impact of cuts to administrative staff who supported drug reviews and inspections, and fed ...
Becker's Hospital Review5d
Cuts to NIH, FDA could slash drug approvals: 5 notes
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Thousands laid off from NIH, FDA and CDC after Supreme Court decision
Thousands of health workers lost their jobs this week after a U.S. Supreme Court ruling cleared the way for the Trump ...